Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 1, 2007, Pages

  Keck, Maggie ^a   Romero Aleshire, Melissa J ^a   Cai, Qi ^a   Hoyer, Patricia B ^a   Brooks, Heddwen L ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

3 HSD4; Diabetes; Estrogen; Perimenopause; Real time PCR

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; COLLAGEN TYPE 4; CYCLINE; EARLY GROWTH RESPONSE FACTOR 1; EPOXIDE; GELATINASE B; GLUCOSE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; 4 VINYL 1 CYCLOHEXENE DIOXIDE; 4-VINYL-1-CYCLOHEXENE DIOXIDE; CYCLOHEXENE DERIVATIVE; HORMONE; RNA; VINYL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MENOPAUSE; MOUSE; NONHUMAN; OVARY INSUFFICIENCY; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HUMAN; ISOLATION AND PURIFICATION; KIDNEY CORTEX; METABOLISM; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY; PREMATURE OVARIAN FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; CYCLOHEXENES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; MENOPAUSE; MICE; MICE, INBRED STRAINS; OVARIAN FAILURE, PREMATURE; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; VINYL COMPOUNDS; WEIGHT GAIN;

EID: 34548028733     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00022.2007     Document Type: Article

References (40)

1. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int 67: s14-s18, 2005.
2. Clarke TR, Bain PA, Greco TL, Payne AH. A novel mouse kidney 3 beta-hydroxysteroid dehydrogenase complementary DNA encodes a 3-ketosteroid reductase instead of a 3 beta- hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase. Mol Endocrinol 7: 1569-1578, 1993.
3. Coggins C, Lewis J, Caggiula A, Castaldo L, Klahr S, Wang S, Beck G. Differences between women and men with chronic renal disease. Nephrol Dial Transplant 13: 1430-1437, 1998.
4. Couzinet B, Meduri G, Lecce MG, Young J, Brailly S, Loosfelt H, Milgrom E, Schaison G. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 86: 5060-5066, 2001.
5. Elliot SJ, Karl M, Berho M, Potier M, Zheng F, Leclercq B, Striker GE, Striker LJ. Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol 162: 1441-1448, 2003.
6. Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol 290: F214-F222, 2006.
7. Hinojosa-Laborde C, Craig T, Zheng W, Ji H, Haywood JR, Sandberg K. Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 44: 405-409, 2004.
8. Hoyer PB, Sipes IG. Assessment of follicle destruction in chemical-induced ovarian toxicity. Annu Rev Pharmacol Toxicol 36: 307-331, 1996.
9. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85: 447-452, 1976.
10. Le May C, Chu K, Hu M, Ortega CS, Simpson ER, Korach KS, Tsai MJ, Mauvais-Jarvis F. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103: 9232-9237, 2006.
11. Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-δδCT Method. Methods 25: 402-408, 2001.
12. Lohff JC, Christian PJ, Marion SL, Arrandale A, Hoyer PB. Characterization of cyclicity and hormonal profile with impending ovarian failure in a novel chemical-induced mouse model of perimenopause. Comput Med Imaging Graph 55: 523-527, 2005.
13. Lohff JC, Christian PJ, Marion SL, Hoyer PB. Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause 13: 482-488, 2006.
14. Maeda M, Yabuki A, Suzuki S, Matsumoto M, Taniguchi K, Nishinakagawa H. Renal lesions in spontaneous insulin-dependent diabetes mellitus in the nonobese diabetic mouse: acute phase of diabetes. Vet Pathol 40: 187-195, 2003.
15. Mankhey RW, Bhatti F, Maric C. 17β-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 288: F399-F405, 2005.
16. Mankhey RW, Wells CC, Bhatti F, Maric C. 17β-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol In press.
17. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47: 1175-1187, 2004.
18. Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17β-estradiol in the aging dahl salt sensitive rat. J Am Soc Nephrol 15: 1546-1556, 2004.
19. Matthews KA, Santoro N, Lasley B, Chang Y, Crawford S, Pasternak RC, Sutton-Tyrrell K, Sowers M. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab 91: 1789-1795, 2006.
20. Mayer LP, Devine PJ, Dyer CA, Hoyer PB. The follicle-deplete mouse ovary produces androgen. Biol Reprod 71: 130-138, 2004.
21. McReynolds MR, Taylor-Garcia KM, Greer KA, Hoying JB, Brooks HL. Renal medullary gene expression in aquaporin-1 null mice. Am J Physiol Renal Physiol 288: F315-F321, 2005.
22. Mulroney SE, Woda C, Johnson M, Pesce C. Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int 56: 944-953, 1999.
23. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11: 319-329, 2000.
24. Nyengaard JR, Flyvbjerg A, Rasch R. The impact of renal growth, regression and regrowth in experimental diabetes mellitus on number and size of proximal and distal tubular cells in the rat kidney. Diabetologia V36: 1126-1131, 1993.
25. Ouar Z, Sole E, Bens M, Rafestin-Oblin ME, Meseguer A, Vandewalle A. Pleiotropic effects of dihydrotestosterone in immortalized mouse proximal tubule cells. Kidney Int 53: 59-66, 1998.
26. Potier M, Karl M, Zheng F, Elliot SJ, Striker GE, Striker LJ. Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol 160: 1877-1885, 2002.
27. Quinkler M, Johanssen S, Bumke-Vogt C, Oelkers W, Bahr V, Diederich S. Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney. Mol Cell Endocrinol 171: 21-24, 2001.
28. Reckelhoff JF, Yanes LL, Iliescu R, Fortepiani LA, Granger JP. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 289: F941-F948, 2005.
29. Riazi S, Maric C, Ecelbarger CA. 17β Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters. Kidney Int 69: 471-480, 2006.
30. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386, 2000.
31. Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81: 1495-1501, 1996.
32. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16: S30-S33, 2005.
33. Schrijvers BF, De Vriese AS, Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25: 971-1010, 2004.
34. Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10: 219-225, 2001.
35. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y, Ciccone E, Wu D, Dunn S, McCue P, Sharma K. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794, 2004.
36. Ushiroyama T, Sugimoto O. Endocrine function of the peri- and postmenopausal ovary. Horm Res 44: 64-68, 1995.
37. Williams JK. A mouse model of the perimenopausal transition: importance for cardiovascular research. Arterioscler Thromb Vasc Biol 25: 1765-1766, 2005.
38. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999.
39. Zeng XR, Jiang Y, Zhang SJ, Hao H, Lee MY. DNA polymerase delta is involved in the cellular response to UV damage in human cells. J Biol Chem 269: 13748-13751, 1994.
40. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factorbeta. J Clin Invest 93: 536-542, 1994.